Effect of perioperative high-quality nursing combined with psychological nursing based on patients with uterine prolapse and enterocele

doi:10.3877/cma.j.issn.1674-392X.2022.02.027

Abstract

Abstract:

Objective

To observe the application effect of perioperative high quality nursing combined with psychological nursing on patients with uterine prolapse and enterocele.

Methods

The 60 patients with uterine prolapse and enterocele admitted to our hospital from February 2017 to July 2020, were selected as the research objects in this study. All patients were given treatment with vaginal hysterectomy and colporrhaphia anterior-posterior, and they were divided into the control group (n=30) and the observation group (n=30). The control group was given routine perioperative nursing, while the observation group was given perioperative high-quality nursing combined with psychological nursing based on the control group. The status of uterine prolapse and oxidative stress factors related to pathogenesis and the influence of quality of life in two groups were compared before and after intervention.

Results

The measurement points of uterine prolapse in the observation group after quality nursing intervention were better than those in the control group (P<0.05). Compared with control group, TGF-β1, matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in observation group were improved after intervention (P<0.05). The quality of life score of the observation group was better than that of the control group after intervention and 3 months after discharge (P<0.05).

Conclusion

The application of perioperative high-quality nursing combined with psychological nursing based on patients with uterine prolapse and enterocele, which has a significant clinical efficacy. It can improve the situation of pelvic organ prolapse and oxidative stress level of patients, and the quality of life has been improved, too.

Key words: Uterine prolapse, Enterocele, Perioperative high-quality nursing, Psychological Nursing

Haiyuan Qiao, Hongmei Wang, Yingying Gao. Effect of perioperative high-quality nursing combined with psychological nursing based on patients with uterine prolapse and enterocele[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2022, 16(02): 241-246.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhshfbwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-392X.2022.02.027

https://zhshfbwkzz.cma-cmc.com.cn/EN/Y2022/V16/I02/241

Figures/Tables 3

References 21

[1]	秦芬，王权. 传统术式与"协和"全盆底重建术治疗子宫脱垂合并肾功能异常的临床疗效观察[J]. 中国计划生育学杂志, 2019, 27(2): 234-236, 240.
[2]	Abhyankar P, Uny I, Semple K, et al. Women’s experiences of receiving care for pelvic organ prolapse: a qualitative study[J]. BMC Womens Health, 2019, 19(1): 1-12.
[3]	张婷婷，张梅娣，范丹丹. 改良阴式子宫切除联合阴道前后壁修补术在子宫脱垂Ⅱ~Ⅲ度合并肠疝中的临床疗效[J/OL]. 中华疝和腹壁外科杂志(电子版), 2021, 15(4): 401-405.
[4]	李亚林，谢吉玉，吴瑾. 人文关怀联合信息支持对子宫全切术患者心理危机及应对方式的影响[J]. 医学临床研究, 2019, 36(5): 922-924.
[5]	刘洋洋. 综合护理在生物反馈电刺激治疗产后盆底功能障碍性疾病的效果分析[J]. 中国冶金工业医学杂志, 2021, 38(5): 609-610.
[6]	顾光华，潘伟康，李怀芳, 等. 腹腔镜下子宫腹壁悬吊联合阴道前壁修补治疗子宫脱垂84例病例分析[J]. 现代妇产科进展, 2021, 30(4): 288-290.
[7]	Belayneh T, Gebeyehu A, Adefris M, et al. Translation, transcultural adaptation, reliability and validation of the pelvic organ prolapse quality of life(P-QoL) in Amharic[J]. Health Qual Life Outcomes, 2019, 17(1): 1-11.
[8]	Hagen S, Kearney R, Goodman K, et al. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial[J]. Trials, 2020, 21(1): 837-849.
[9]	Paka C, Hallock JL, Trock B, et al. Urinary incontinence and pelvic organ prolapse knowledge, care-seeking, and embarrassment in women planning bariatric surgery: a cross-sectional study[J]. Female Pelvic Med Reconstr Surg, 2020, 26(4): 276-280.
[10]	张小红，刘志红，洪莉. TGF-β1, MMP-2, TIMP-2与子宫脱垂发生的相关性[J]. 中国性科学, 2016, 25(7): 35-38.
[11]	Alay I, Kaya C, Cengiz H, et al. Apical pelvic organ prolapse repair via vaginal-assisted natural orifice transluminal endoscopic surgery: Initial experience from a tertiary care hospital[J]. Asian J Endosc Surg, 2021, 14(3): 346-352.
[12]	Belayneh T, Gebeyehu A, Adefris M, et al. Pelvic organ prolapse surgery and health-related quality of life: a follow-up study[J]. BMC Womens Health, 2021, 21(1): 4.
[13]	罗红英. 人性化护理用于阴式子宫切除术治疗老年子宫脱垂的作用探讨[J]. 现代消化及介入诊疗, 2019, 24(S1): 1263.
[14]	戴文娟，陆建红，李加芬. 人文医疗在阴式全子宫切除术联合阴道后壁修补术治疗子宫脱垂合并肠疝患者中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2021, 15(1): 71-75.
[15]	吴玲. 早期盆底肌康复训练联合延续性护理对产后子宫脱垂患者盆底肌电及产后抑郁的影响[J]. 河北医药, 2020, 42(22): 3504-3506, 3510.
[16]	刘彩英，田校洋. 优质护理服务模式对子宫脱垂患者护理的影响研究[J]. 现代消化及介入诊疗, 2019, 24(S1): 1794.
[17]	李自梅. 集束化护理在脱垂子宫阴式子宫全切术后护理中的应用分析[J]. 中国药物与临床, 2021, 21(9): 1635-1636.
[18]	田黇，彭继蓉. 护理干预对产妇盆底肌肉康复治疗后盆底功能及子宫脱垂的改善作用[J]. 现代消化及介入诊疗, 2019, 24(S1): 1325-1326.
[19]	王亚男，王国建，赵国玉. 补中益气汤联合运动训练对产后盆底功能障碍患者盆底肌情况及MMP-2、TIMP-2、TGF-β1表达水平的影响[J]. 长春中医药大学学报, 2021, 37(2): 355-358.
[20]	杨青，刘成，李秉枢, 等. 氧化应激对盆底器官脱垂患者子宫旁韧带组织细胞外基质代谢的影响[J]. 中国计划生育和妇产科, 2016, 8(1): 53-57.
[21]	Raju R, Linder BJ. Evaluation and management of pelvic organ prolapse[J]. Mayo Clin Proc, 2021, 96(12): 3122-3129.

组别	例数	阶段	Aa	Ap	Ba	Bp	C	D	TVL
对照组	30	干预前	0.54±0.31	-1.16±0.14	-1.79±0.62	-1.37±0.15	-0.21±0.05	2.15±1.17	7.05±1.04
对照组	30	干预后	-1.11±0.29^a	-1.28±0.17^a	-1.24±0.15^a	-1.92±0.36^a	-5.07±0.38^a	-0.98±0.42^a	7.65±1.15^a
观察组	30	干预前	0.55±0.32	-1.15±0.17	-1.80±0.70	-1.35±0.18	-0.20±0.06	2.16±1.25	7.06±1.12
观察组	30	干预后	-2.28±0.15^ab	-2.35±0.26^ab	-2.33±0.33^ab	-2.92±0.35^ab	-7.25±0.45^ab	-1.72±0.92^ab	8.66±1.18^ab

组别	例数	阶段	Aa	Ap	Ba	Bp	C	D	TVL
对照组	30	干预前	0.54±0.31	-1.16±0.14	-1.79±0.62	-1.37±0.15	-0.21±0.05	2.15±1.17	7.05±1.04
对照组	30	干预后	-1.11±0.29^a	-1.28±0.17^a	-1.24±0.15^a	-1.92±0.36^a	-5.07±0.38^a	-0.98±0.42^a	7.65±1.15^a
观察组	30	干预前	0.55±0.32	-1.15±0.17	-1.80±0.70	-1.35±0.18	-0.20±0.06	2.16±1.25	7.06±1.12
观察组	30	干预后	-2.28±0.15^ab	-2.35±0.26^ab	-2.33±0.33^ab	-2.92±0.35^ab	-7.25±0.45^ab	-1.72±0.92^ab	8.66±1.18^ab

组别	例数	阶段	TGF-β1	MMP-2	TIMP-2
对照组	30	干预前	0.21±0.23	0.92±0.41	0.33±0.24
		干预后	0.39±0.41^a	0.72±0.21^a	0.56±0.17^a
观察组	30	干预前	0.23±0.28	0.93±0.52	0.35±0.25
		干预后	0.66±0.27^ab	0.32±0.33^ab	0.82±0.44^ab

组别	例数	阶段	TGF-β1	MMP-2	TIMP-2
对照组	30	干预前	0.21±0.23	0.92±0.41	0.33±0.24
		干预后	0.39±0.41^a	0.72±0.21^a	0.56±0.17^a
观察组	30	干预前	0.23±0.28	0.93±0.52	0.35±0.25
		干预后	0.66±0.27^ab	0.32±0.33^ab	0.82±0.44^ab

组别	例数	阶段	POPDI-6	CARDI-8	UDI-6
对照组	30	干预前	32.56±5.72	28.62±4.27	30.95±3.97
		干预后	50.17±6.33^a	40.15±2.95^a	39.11±5.36^a
		出院3个月后	50.55±6.76^abc	42.82±1.72^abc	40.17±5.11^abc
观察组	30	干预前	33.04±4.98	28.99±4.33	31.02±4.05
		干预后	62.36±5.32^a	50.25±3.12^a	55.77±6.23^a
		出院3个月后	65.34±3.28^abc	51.28±5.12^abc	58.35±5.94^abc

Please choose a citation manager

Content to export